EU approves Gilead's HIV drug combo

02/24/2005 | iWon

Gilead Sciences reports it received European Commission approval to market its HIV drug Truvada in the European Union. Truvada combines two HIV drugs, Emtriva and Viread, in one pill, which can be taken once a day along with other antiretroviral medicines.

View Full Article in:

iWon

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC